Stockreport

Clasp Therapeutics Launches With $150 Million to Pioneer Precision Immuno-Oncology Using Next-Generation T Cell Engagers With Unparalleled Specificity [Yahoo! Finance]

Iron Mountain Incorporated (Delaware)Common Stock REIT  (IRM) 
Last iron mountain incorporated (delaware)common stock reit earnings: 2/13 06:00 am Check Earnings Report
PDF Platform enables modular T cell engagers tailored to oncogenic driver mutations for highly specific tumor targeting Founders include cancer genetics pioneer Bert Voge [Read more]